Therapeutic Applications of Ribozymes

"... an impressive collection of ribozyme applications...a useful investment for anyone who contemplates or is actively using ribozymes for target RNA inactivations."-Nature Medicine

• Small Efficient Hammerhead Ribozymes.- The Hairpin Ribozyme.- Molecular Manipulations of the Catalytic RNAs from the Human Hepatitis Delta Virus.- The Design, Production, and Validation of an Anti-HIV Type 1 Ribozyme.- Methods for Treating HIV by Gene Therapy Using Ribozymes.- An Expression Vector for Multiple Ribozymes.- Viral RNA Targets for Ribozymes.- Hammerhead Ribozyme-Mediated Cleavage of Hepatitis B Virus RNA.- Bovine Leukemia Virus Ribozymes.- Use of Ribozymes to Specifically Alter the MDR-1 Phenotype.- Adenoviral-Mediated Anti-H-ras Ribozyme for the Treatment of Bladder Cancer.- Tissue-Specific Delivery of an anti-H-ras Ribozyme Against Malignant Melanoma.- Ribozymes as a Novel Approach for the Treatment of Human Pancreatic carcinoma.- K-rasRibozyme for Lung Cancer.- Anti-c-erb-B-2 Ribozyme for Breast Cancer.- Ribozymes.- Preformed Ribozymes.- Folate-Polylysine-Mediated Delivery of a Multiunit Anti-BCR/ABL Ribozyme to BCR/ABL-Transformed 32D Cells.- Ribozymes Targeted Against AML1/MTG8.- Ribozyme Targeting of the Growth Factor Pleiotrophin.- Ribozyme-Mediated Inhibition of Cell Proliferation.- Inhibition of ?APP Synthesis by Ribozymes and Oligonucleotides in a Coupled Reticulocyte Transcription Translation System.- Selective Modification of Fatty Acid Synthesis Pathway by Expression of an Acetyl-CoA Carboxylase-Specific Ribozyme Gene.- In Vivo Knockout of a Tissue-Specific Gene by Synthetic Ribozymes.- Ribozyme-Mediated Downregulation of Gene Expression in Transgenic Mice.- Targeted Cleavage of RNA Using External Guide Sequences and Eukaryotic RNase P.- Application of In Vitro Selection in Design of External Guide Sequences That Direct Efficient Cleavage of RNA by RNase P.- A PCR-Based Approach to Hammerhead Ribozyme Synthesis.- Measurement of RibozymeActivity Using RNase Protection.